Skip to main content
Top
Published in: Neurocritical Care 1/2021

Open Access 01-08-2021 | Ultrasound | Original work

New Approaches to Critical Illness Polyneuromyopathy: High-Resolution Neuromuscular Ultrasound Characteristics and Cytokine Profiling

Authors: Anna Lena Fisse, Caroline May, Jeremias Motte, Xiomara Pedreiturria, Thomas G. K. Breuer, Christiane Schneider-Gold, Katrin Marcus, Ralf Gold, Min-Suk Yoon, Kalliopi Pitarokoili

Published in: Neurocritical Care | Issue 1/2021

Login to get access

Abstract

Background

Diagnosis of intensive care unit acquired weakness (ICUAW) is challenging. Pathogenesis of underlying critical illness polyneuromyopathy (CIPNM) remains incompletely understood. This exploratory study investigated whether longitudinal neuromuscular ultrasound examinations and cytokine analyses in correlation to classical clinical and electrophysiological assessment contribute to the understanding of CIPNM.

Methods

Intensive care unit patients were examined every 7 days until discharge from hospital. Clinical status, nerve conduction studies, electromyography as well as ultrasound of peripheral nerves and tibial anterior muscle were performed. Cytokine levels were analyzed by a bead-based multiplex assay system.

Results

Of 248 screened patients, 35 patients were included at median of 6 days (IQR: 8) after admission to intensive care unit. Axonal damage was the main feature of CIPNM. At the peak of CIPNM (7 days after inclusion), nerve ultrasound showed cross-sectional area increase of tibial nerve as a sign of inflammatory edema as well as hypoechoic nerves as a possible sign of inflammation. Cytokine analyses showed signs of monocyte and macrophage activation at this stage. Fourteen days after inclusion, cytokines indicated systemic immune response as well as profiles associated to neovascularization and regeneration.

Conclusions

Exploratory neuromuscular ultrasound and cytokine analyses showed signs of inflammation like macrophage and monocyte activation at the peak of CIPNM followed by a systemic immune response parallel to axonal damage. This underlines the role of both axonal damage and inflammation in pathogenesis of CIPNM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hermans G, den Berghe GV. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19:274.CrossRef Hermans G, den Berghe GV. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19:274.CrossRef
2.
go back to reference Senger D, Erbguth F. Critical illness myopathy and polyneuropathy. Medizinische Klinik Intensivmedizin und Notfallmedizin. 2017;112:589–96.CrossRef Senger D, Erbguth F. Critical illness myopathy and polyneuropathy. Medizinische Klinik Intensivmedizin und Notfallmedizin. 2017;112:589–96.CrossRef
3.
go back to reference Solana LS, Bilbao IG, García PR, Agea JLD, Costa CL. Disfunción neuromuscular adquirida en la unidad de cuidados intensivos. Enfermería Intensiva. 2018;29:128–37. Solana LS, Bilbao IG, García PR, Agea JLD, Costa CL. Disfunción neuromuscular adquirida en la unidad de cuidados intensivos. Enfermería Intensiva. 2018;29:128–37.
4.
go back to reference Kelmenson DA, Held N, Allen RR, Quan D, Burnham EL, Clark BJ, et al. Outcomes of ICU patients with a discharge diagnosis of critical illness polyneuromyopathy. Crit Care Med. 2017;45:2055–60.CrossRef Kelmenson DA, Held N, Allen RR, Quan D, Burnham EL, Clark BJ, et al. Outcomes of ICU patients with a discharge diagnosis of critical illness polyneuromyopathy. Crit Care Med. 2017;45:2055–60.CrossRef
5.
go back to reference Jonghe BD, Sharshar T, Lefaucheur J-P, Authier F-J, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288:2859.CrossRef Jonghe BD, Sharshar T, Lefaucheur J-P, Authier F-J, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288:2859.CrossRef
6.
go back to reference Wieske L, Verhamme C, Witteveen E, Bouwes A, Dettling-Ihnenfeldt DS, van der Schaaf M, et al. Feasibility and diagnostic accuracy of early electrophysiological recordings for ICU-acquired weakness: an observational cohort study. Neurocrit Care. 2015;22:385–94.CrossRef Wieske L, Verhamme C, Witteveen E, Bouwes A, Dettling-Ihnenfeldt DS, van der Schaaf M, et al. Feasibility and diagnostic accuracy of early electrophysiological recordings for ICU-acquired weakness: an observational cohort study. Neurocrit Care. 2015;22:385–94.CrossRef
7.
go back to reference Formenti P, Umbrello M, Coppola S, Froio S, Chiumello D. Clinical review: peripheral muscular ultrasound in the ICU. Ann Intensive Care. 2019;9:57.CrossRef Formenti P, Umbrello M, Coppola S, Froio S, Chiumello D. Clinical review: peripheral muscular ultrasound in the ICU. Ann Intensive Care. 2019;9:57.CrossRef
8.
go back to reference Patejdl R, Walter U, Rosener S, Sauer M, Reuter DA, Ehler J. Muscular ultrasound, syndecan-1 and procalcitonin serum levels to assess intensive care unit-acquired weakness. Can J Neurol Sci. 2019;46:234–42.CrossRef Patejdl R, Walter U, Rosener S, Sauer M, Reuter DA, Ehler J. Muscular ultrasound, syndecan-1 and procalcitonin serum levels to assess intensive care unit-acquired weakness. Can J Neurol Sci. 2019;46:234–42.CrossRef
9.
go back to reference Grimm A, Teschner U, Porzelius C, Ludewig K, Zielske J, Witte OW, et al. Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care. 2013;17:1–1.CrossRef Grimm A, Teschner U, Porzelius C, Ludewig K, Zielske J, Witte OW, et al. Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care. 2013;17:1–1.CrossRef
10.
go back to reference Witteveen E, Sommers J, Wieske L, Doorduin J, van Alfen N, Schultz MJ, et al. Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study. Ann Intensive Care. 2017;7:1–9.CrossRef Witteveen E, Sommers J, Wieske L, Doorduin J, van Alfen N, Schultz MJ, et al. Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study. Ann Intensive Care. 2017;7:1–9.CrossRef
11.
go back to reference Koch S, Bierbrauer J, Haas K, Wolter S, Grosskreutz J, Luft FC, et al. Critical illness polyneuropathy in ICU patients is related to reduced motor nerve excitability caused by reduced sodium permeability. Intensive Care Med. 2016;4:1–12.CrossRef Koch S, Bierbrauer J, Haas K, Wolter S, Grosskreutz J, Luft FC, et al. Critical illness polyneuropathy in ICU patients is related to reduced motor nerve excitability caused by reduced sodium permeability. Intensive Care Med. 2016;4:1–12.CrossRef
12.
go back to reference Friedrich O, Reid MB, den Berghe GV, Vanhorebeek I, Hermans G, Rich MM, et al. The sick and the weak: neuropathies/myopathies in the critically Ill. Physiol Rev. 2015;95:1025–109.CrossRef Friedrich O, Reid MB, den Berghe GV, Vanhorebeek I, Hermans G, Rich MM, et al. The sick and the weak: neuropathies/myopathies in the critically Ill. Physiol Rev. 2015;95:1025–109.CrossRef
13.
go back to reference Witteveen E, Wieske L, van der Poll T, van der Schaaf M, van Schaik IN, Schultz MJ, et al. Increased early systemic inflammation in ICU-acquired weakness: a prospective observational cohort study. Crit Care Med. 2017;45:972–9.CrossRef Witteveen E, Wieske L, van der Poll T, van der Schaaf M, van Schaik IN, Schultz MJ, et al. Increased early systemic inflammation in ICU-acquired weakness: a prospective observational cohort study. Crit Care Med. 2017;45:972–9.CrossRef
14.
go back to reference Witteveen E, Wieske L, de Beer FM, Juffermans NP, Verhamme C, Schultz MJ, et al. No association between systemic complement activation and intensive care unit-acquired weakness. Ann Transl Med. 2018;6:115.CrossRef Witteveen E, Wieske L, de Beer FM, Juffermans NP, Verhamme C, Schultz MJ, et al. No association between systemic complement activation and intensive care unit-acquired weakness. Ann Transl Med. 2018;6:115.CrossRef
15.
go back to reference Witteveen E, Wieske L, Verhamme C, Schultz MJ, van Schaik IN, Horn J. Muscle and nerve inflammation in intensive care unit-acquired weakness: a systematic translational review. J Neurol Sci. 2014;345:15–25.CrossRef Witteveen E, Wieske L, Verhamme C, Schultz MJ, van Schaik IN, Horn J. Muscle and nerve inflammation in intensive care unit-acquired weakness: a systematic translational review. J Neurol Sci. 2014;345:15–25.CrossRef
16.
go back to reference American association of Neuromuscular & Electrodiagnostic. Proper performance and interpretation of electrodiagnostic studies. Muscle Nerve. 2006;33:436–9.CrossRef American association of Neuromuscular & Electrodiagnostic. Proper performance and interpretation of electrodiagnostic studies. Muscle Nerve. 2006;33:436–9.CrossRef
17.
go back to reference Stöhr M, Pfister R. Klinische Elektromyographie und Neurographie. 6th ed. Kohlhammer: Lehrbuch und Atlas; 2014. Stöhr M, Pfister R. Klinische Elektromyographie und Neurographie. 6th ed. Kohlhammer: Lehrbuch und Atlas; 2014.
18.
go back to reference Stevens RD, Marshall SA, Cornblath DR, Hoke A, Needham DM, de Jonghe B, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009;37:S299–308.CrossRef Stevens RD, Marshall SA, Cornblath DR, Hoke A, Needham DM, de Jonghe B, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009;37:S299–308.CrossRef
19.
go back to reference Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy. Clin Neurophysiol. 2014;125:635–41.CrossRef Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy. Clin Neurophysiol. 2014;125:635–41.CrossRef
20.
go back to reference Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon M-S. Cross sectional area reference values for sonography of peripheral nerves and brachial plexus. Clin Neurophysiol. 2013;124:1881–8.CrossRef Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon M-S. Cross sectional area reference values for sonography of peripheral nerves and brachial plexus. Clin Neurophysiol. 2013;124:1881–8.CrossRef
21.
go back to reference Fisse AL, Pitarokoili K, Motte J, Gamber D, Kerasnoudis A, Gold R, et al. Nerve echogenicity and intranerve CSA variability in high-resolution nerve ultrasound (HRUS) in chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol. 2019;266:468–75.CrossRef Fisse AL, Pitarokoili K, Motte J, Gamber D, Kerasnoudis A, Gold R, et al. Nerve echogenicity and intranerve CSA variability in high-resolution nerve ultrasound (HRUS) in chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol. 2019;266:468–75.CrossRef
22.
go back to reference Heckmatt JZ, Leeman S, Dubowitz V. Ultrasound imaging in the diagnosis of muscle disease. J Pediatr. 1982;101:656–60.CrossRef Heckmatt JZ, Leeman S, Dubowitz V. Ultrasound imaging in the diagnosis of muscle disease. J Pediatr. 1982;101:656–60.CrossRef
23.
go back to reference Bender R, Lange S. Adjusting for multiple testing—when and how? J Clin Epidemiol. 2001;54:343–9.CrossRef Bender R, Lange S. Adjusting for multiple testing—when and how? J Clin Epidemiol. 2001;54:343–9.CrossRef
24.
go back to reference Gold R, Archelos JJ, Hartung HP. Mechanisms of immune regulation in the peripheral nervous system. Brain Pathol. 1999;9:343–60.CrossRef Gold R, Archelos JJ, Hartung HP. Mechanisms of immune regulation in the peripheral nervous system. Brain Pathol. 1999;9:343–60.CrossRef
25.
go back to reference Härtig F, Ross M, Dammeier NM, Fedtke N, Heiling B, Axer H, et al. Nerve ultrasound predicts treatment response in chronic inflammatory demyelinating polyradiculoneuropathy-a prospective follow-up. Neurotherapeutics. 2018;15:439–51.CrossRef Härtig F, Ross M, Dammeier NM, Fedtke N, Heiling B, Axer H, et al. Nerve ultrasound predicts treatment response in chronic inflammatory demyelinating polyradiculoneuropathy-a prospective follow-up. Neurotherapeutics. 2018;15:439–51.CrossRef
26.
go back to reference Hanewinckel R, Drenthen J, van Oijen M, Hofman A, van Doorn PA, Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology. 2016;87:1892–8.CrossRef Hanewinckel R, Drenthen J, van Oijen M, Hofman A, van Doorn PA, Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology. 2016;87:1892–8.CrossRef
27.
go back to reference Kollmar R. Critical illness polyneuropathy and myopathy as neurological complications of sepsis. Der Nervenarzt. 2016;87:236–45.CrossRef Kollmar R. Critical illness polyneuropathy and myopathy as neurological complications of sepsis. Der Nervenarzt. 2016;87:236–45.CrossRef
28.
go back to reference Shepherd SJ, Newman R, Brett SJ, Griffith DM. Pharmacological therapy for the prevention and treatment of weakness after critical illness. Crit Care Med. 2016;44:1198–205.CrossRef Shepherd SJ, Newman R, Brett SJ, Griffith DM. Pharmacological therapy for the prevention and treatment of weakness after critical illness. Crit Care Med. 2016;44:1198–205.CrossRef
29.
go back to reference Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017;43:1751–63.CrossRef Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017;43:1751–63.CrossRef
30.
go back to reference Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot J-P, Siami S, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. New Engl J Med. 2018;378:809–18.CrossRef Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot J-P, Siami S, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. New Engl J Med. 2018;378:809–18.CrossRef
31.
go back to reference Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. New Engl J Med. 2018;378:797–808.CrossRef Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. New Engl J Med. 2018;378:797–808.CrossRef
32.
go back to reference Schuld A, Birkmann S, Beitinger P, Haack M, Kraus T, Dalal MA, et al. Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Exp Clin Endocrinol Diabetes. 2006;114:322–8.CrossRef Schuld A, Birkmann S, Beitinger P, Haack M, Kraus T, Dalal MA, et al. Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Exp Clin Endocrinol Diabetes. 2006;114:322–8.CrossRef
33.
go back to reference van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia-a clinical research center study. J Clin Endocrinol Metab. 1996;81:3604–6.PubMed van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia-a clinical research center study. J Clin Endocrinol Metab. 1996;81:3604–6.PubMed
34.
go back to reference Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801–10.CrossRef Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801–10.CrossRef
35.
go back to reference The ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526–33. The ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526–33.
Metadata
Title
New Approaches to Critical Illness Polyneuromyopathy: High-Resolution Neuromuscular Ultrasound Characteristics and Cytokine Profiling
Authors
Anna Lena Fisse
Caroline May
Jeremias Motte
Xiomara Pedreiturria
Thomas G. K. Breuer
Christiane Schneider-Gold
Katrin Marcus
Ralf Gold
Min-Suk Yoon
Kalliopi Pitarokoili
Publication date
01-08-2021
Publisher
Springer US
Published in
Neurocritical Care / Issue 1/2021
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-020-01148-2

Other articles of this Issue 1/2021

Neurocritical Care 1/2021 Go to the issue